Bastia Odi Tablet 10mg (Donepezil Hydrochloride Monohydrate)

Adult dose

As Donepezil Hydrochloride, administer 5 mg once daily before bedtime. After administering 5 mg for 4-6 weeks, evaluate the clinical response to consider increasing the dose up to 10 mg. When increasing the dose to 10 mg a day, administration should be done carefully while monitoring for gastrointestinal adverse reactions. This medication is in the form of an orally disintegrating tablet that can be placed on the tongue to dissolve and be taken with or without water.

Child dose

No experience with use in children.

This medication contains the artificial sweetener aspartame, and should not be administered to patients with certain genetic disorders like phenylketonuria. Furthermore, those with allergies to any components of this medication, as well as pregnant or lactating women, and patients with genetic issues such as lactose intolerance should not use this drug. Patients with a history of heart disease or peptic ulcers, asthma, or obstructive pulmonary disease should use this medication cautiously, as symptoms may worsen. This drug can cause a variety of serious adverse reactions, including irregular heartbeats, gastrointestinal bleeding, liver dysfunction, cerebrovascular issues, and movement disorders, so if any symptoms occur, the medication should be stopped immediately, and a physician should be consulted. During administration, the patient’s condition should be regularly monitored, and if there is no therapeutic effect, discontinuation of the medication is advisable. This drug may cause heart conduction anomalies, so patients with heart conditions require precise monitoring, including electrocardiograms. Additionally, the medication may stimulate gastric acid secretion, so patients with peptic ulcers should be careful of symptom aggravation. It may affect driving or machinery operation, so caution is necessary during initial use or with dosage changes. Pregnant or nursing women should avoid this medication unless absolutely necessary and should consult a specialist if needed. Safety in children has not been established, so it is generally not used in this population. This medication can interact with various other drugs; therefore, anyone taking other medications must consult a physician or pharmacist. In cases of overdose, severe symptoms such as nausea, vomiting, bradycardia, and respiratory depression may occur, requiring immediate treatment. This drug is taken in oral dissolving tablet form, placed on the tongue to dissolve, and should be stored out of reach of children and protected from light.

Serious side effects

Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweats, paleness, severe rash with high fever, blisters, skin peeling, pain in mouth/eyes mucous membranes, shortness of breath or difficulty breathing, asthma attack, respiratory distress associated with cough and fever, yellowing of skin or eyes (jaundice), extreme lethargy, sudden and severe headache, lightning headache, seizures, confusion, vision distortion, paralysis, urination.

Mild side effects

• Nausea
• vomiting
• diarrhea
• loss of appetite
• headache
• fatigue
• insomnia
• dizziness
• drowsiness
• tremors

This medication should be stored in a tightly sealed container to prevent exposure to air or moisture. The recommended storage temperature is between 1 and 30 degrees Celsius at room temperature.

Appearance

White to almost white circular orally disintegrating tablet

Package unit

30 tablets